CVS Health Corporation
CVS
$65.75
$0.911.40%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 1,789.66% | -95.08% | 59.03% | -45.60% | -9.51% |
Total Depreciation and Amortization | -1.21% | 0.87% | 1.14% | 0.35% | 0.62% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -239.12% | 5,414.29% | 110.14% | -130.26% | 280.00% |
Change in Net Operating Assets | 83.44% | -1,577.64% | -94.08% | 145.02% | -725.68% |
Cash from Operations | 349.66% | -124.12% | -37.00% | 286.00% | -197.05% |
Capital Expenditure | -14.63% | -5.02% | 9.50% | 22.61% | -67.16% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 16.67% | 75.00% | -92.00% | 79.17% | -566.67% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 108.67% | -183.81% | 31.16% | -546.45% | -1.44% |
Cash from Investing | 83.66% | -105.97% | 22.40% | -68.60% | -61.09% |
Total Debt Issued | 612.17% | -75.41% | -3.14% | 1,159.50% | 120.00% |
Total Debt Repaid | -108.78% | -570.78% | -1,116.67% | 95.83% | 54.38% |
Issuance of Common Stock | -83.33% | 356.00% | -87.68% | 480.00% | -71.31% |
Repurchase of Common Stock | 0.00% | 97.18% | 95.36% | -61,060.00% | -25.00% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -0.12% | 2.45% | -2.14% | -7.83% | 0.00% |
Other Financing Activities | 500.00% | 166.67% | 109.09% | -466.67% | 110.11% |
Cash from Financing | 127.14% | -227.14% | 201.79% | -26.23% | 63.96% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 130.70% | -309.36% | 71.49% | 132.62% | -544.95% |